These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25794632)

  • 1. Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
    Mormile R
    Immunol Lett; 2015 May; 165(1):60-1. PubMed ID: 25794632
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
    Le Houézec D
    Immunol Res; 2014 Dec; 60(2-3):219-25. PubMed ID: 25395338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new French paradox: HBV vaccination.
    Braillon A
    J Hepatol; 2009 Sep; 51(3):597-8; author reply 598-9. PubMed ID: 19586678
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B vaccination and central nervous system demyelination: an immunological approach.
    Piaggio E; Ben Younes A; Desbois S; Gout O; Tourbah A; Lyon-Caen O; Liblau RS
    J Autoimmun; 2005 Feb; 24(1):33-7. PubMed ID: 15725574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
    Cassidy A; Mossman S; Olivieri A; De Ridder M; Leroux-Roels G
    Expert Rev Vaccines; 2011 Dec; 10(12):1709-15. PubMed ID: 22085174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-responders to hepatitis B vaccination: a review.
    Kubba AK; Taylor P; Graneek B; Strobel S
    Commun Dis Public Health; 2003 Jun; 6(2):106-12. PubMed ID: 12889288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
    Tosti ME; Traversa G; Bianco E; Mele A
    Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.
    Demicheli V; Rivetti A; Di Pietrantonj C; Clements CJ; Jefferson T
    J Viral Hepat; 2003 Sep; 10(5):343-4. PubMed ID: 12969184
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of infection control in prevention of hepatitis B virus (HBV) in hemodialysis (HD) patients.
    Yassin MH; Gupta V
    Infect Disord Drug Targets; 2013 Jun; 13(3):162-8. PubMed ID: 23961738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunization and problems of newborns receiving hepatitis B vaccines in countryside].
    Li RC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):241. PubMed ID: 12716529
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B Vaccines.
    Pattyn J; Hendrickx G; Vorsters A; Van Damme P
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S343-S351. PubMed ID: 34590138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor vaccine-related immunity against HBV in children with autoimmune diseases: Early or late sign of immunological disorder?
    Antonucci R; Frassetto R; Vacca N; Mura D; Lampis R; Castiglia P; Sotgiu G; Piana A; Clemente MG
    Vaccine; 2019 May; 37(19):2527-2528. PubMed ID: 30992122
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z; Li L; Ruan B
    Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.
    Luongo M; Critelli R; Grottola A; Gitto S; Bernabucci V; Bevini M; Vecchi C; Montagnani G; Villa E
    J Clin Virol; 2015 Jan; 62():89-91. PubMed ID: 25542480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.